GREATER CLEVELAND PARTNERSHIP

Lobbying for GREATER CLEVELAND PARTNERSHIP

Filing 1st Quarter - Report

Reporting period

1st Quarter 2026

Jan 1 - Mar 31 · Posted Apr 20, 2026

Expenses

$100,000.00

What this organization spent lobbying with its own staff. Reported using A: the three LDA methods count different costs, so an expenses figure is not comparable across filers that used different ones.

Client based in

Ohio

Official filing document

Government bodies contacted 13

Commerce, Dept of (DOC)
Defense, Dept of (DOD)
Economic Development Administration
HOUSE OF REPRESENTATIVES
Minority Business Development Agency
Natl Aeronautics & Space Administration (NASA)
Natl Institutes of Health (NIH)
SENATE
Small Business Administration (SBA)
Transportation, Dept of (DOT)
Treasury, Dept of
U.S. Trade Representative (USTR)
White House Office

The chambers, agencies and offices the filer named. It does not say who inside them was contacted, or when.

Lobbying activity 16

Aerospace

NASA funding

Budget/Appropriations

Federal budget issues; NASA, Workforce, Research Funding

Economics/Economic Development

Economic development policy

Natural Resources

Great Lakes Restoration Initiative

Science/Technology

NASA

Roads/Highway

Transportation funding

Transportation

Transportation funding; Burke airport closure

Manufacturing

Economic development policy; manufacturing workforce program support

Defense

Funding for NASA facilities

Small Business

Small business policies and the impact of certain policies on small businesses

Taxation/Internal Revenue Code

Benefits and impact of CDFI Fund and tools, including the New Market Tax Credit program. Benefits and impact of Opportunity Zones.

Real Estate/Land Use/Conservation

New Market Tax Credit program's impact on local real estate and development.

Urban Development/Municipalities

Opportunity Zones and New Market Tax Credit program's impact on urban development.

Trade (domestic/foreign)

Discussed trade and impact from tariffs

Tariff (miscellaneous tariff bills)

Discussed trade and impact from tariffs

Medical/Disease Research/Clinical Labs

Discussed the importance and impact of funding for innovation and research, especially as it relates to NIH investments

Source: federal Lobbying Disclosure Act filing, reproduced as filed. Bills are parsed from the activity descriptions.